Tauroursodeoxycholic Acid For Treatment Of Primary Biliary Cirrhosis. A Dose-response Study
| Effect | Decrease |
| Trial Design | Non-controlled trial |
| Trial Length | n/a |
| Number of Subjects | 24 |
| Sex | n/a |
500, 1000, and 1500mg of TUDCA were tested over 6 months to see dose-response effects. There was a insignificant dose-response, with 1500mg being the most effective at reducing liver enzyme levels but 500mg being most economical; total cholesterol was reduced with 1000 and 1500mg.
Diarrhea was the only side-effect noted.
